AMY MURPHY: Open Payments
NPI 1891984977 · VENICE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$904 in 42 payments from 14 companies in 2025. Trend: 2023 $1,119 · 2024 $1,514 · 2025 $904
Food & beverage: $880Education: $24
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $236 |
| Janssen Biotech, Inc. | 5 | $112 |
| Regeneron Healthcare Solutions, Inc. | 3 | $93 |
| Amgen Inc. | 4 | $75 |
| Novartis Pharmaceuticals Corporation | 3 | $63 |
| Incyte Corporation | 3 | $56 |
| Almirall LLC | 2 | $49 |
| Biofrontera Inc. | 2 | $46 |
| GENZYME CORPORATION | 1 | $38 |
| Lilly USA, LLC | 1 | $34 |
Products named: SKYRIZI, DUPIXENT, TREMFYA, RINVOQ, OTEZLA, OPZELURA, AMELUZ, Rhapsido.
Industry payments across FL — which companies pay providers there.
